Shionogi & Co., Ltd. (OTCMKTS:SGIOF) Stock Price Down 12.6% – Should You Sell?
by Scott Moore · The Cerbat GemShionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) fell 12.6% during mid-day trading on Friday . The company traded as low as $19.10 and last traded at $19.10. 150 shares changed hands during trading, a decline of 73% from the average session volume of 550 shares. The stock had previously closed at $21.85.
Shionogi & Co., Ltd. Stock Performance
The stock has a 50-day moving average price of $21.99 and a 200-day moving average price of $18.65.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. is a research-driven pharmaceutical company headquartered in Osaka, Japan, with origins dating back to 1878. The company concentrates on the discovery, development and sale of prescription medicines in key therapeutic areas, including infectious diseases, pain management, cardiovascular and metabolic disorders, central nervous system disorders and oncology. Shionogi’s mission emphasizes addressing unmet medical needs, particularly in the field of antimicrobial resistance, where it has developed both small-molecule antibiotics and novel treatment approaches.
The firm’s product portfolio comprises marketed therapies such as Cresemba (isavuconazole) for invasive fungal infections, and Fetroja (cefiderocol), a siderophore cephalosporin antibiotic for multidrug-resistant Gram-negative infections.